Renaissance Capital’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7,957
| Closed | -$60K | – | 76 |
|
|
2023
Q1 | $60K | Sell |
7,957
-1,019
| -11% | -$7.68K | 0.04% | 87 |
|
|
2022
Q4 | $90.9K | Buy |
+8,976
| New | +$90.9K | 0.07% | 86 |
|
|
2022
Q1 | – | Sell |
-10,327
| Closed | -$148K | – | 101 |
|
|
2021
Q4 | $148K | Sell |
10,327
-1,815
| -15% | -$26K | 0.04% | 107 |
|
|
2021
Q3 | $243K | Sell |
12,142
-16,349
| -57% | -$327K | 0.05% | 100 |
|
|
2021
Q2 | $627K | Sell |
28,491
-6,270
| -18% | -$138K | 0.1% | 71 |
|
|
2021
Q1 | $1.18M | Buy |
+34,761
| New | +$1.18M | 0.17% | 57 |
|